Loading clinical trials...
Loading clinical trials...
Current standard treatments for lymphoma involving the central nervous system include chemotherapy or whole brain radiation therapy (WBRT). However, many patients do not respond to this treatment, and...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
Collaborators
NCT00131014 · Non-Hodgkin's Lymphoma, Hodgkin's Disease, and more
NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more
NCT06931652 · Primary CNS Lymphoma (PCNSL)
NCT06667687 · Non-Hodgkin's Lymphoma
NCT05098613 · Non-Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma (B-NHL), and more
Massachusetts General Hospital
Boston, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions